Wednesday, February 18, 2026 Does Multiple Sclerosis Start in Childhood? Tanuja Chitnis, MD

Why It Matters

Recognizing MS onset in childhood changes diagnostic pathways, accelerates treatment decisions and biomarker-driven monitoring, and could shift research and public-health efforts toward earlier intervention and prevention. Improved pediatric detection and integrated translational research promise to refine therapies and reduce long-term disability.

Summary

Dr. Tanuja Chitnis, a leader in neuroimmunology, argued that many cases of multiple sclerosis originate in childhood and reviewed advances in recognizing, diagnosing and treating pediatric MS. Using a representative 12-year-old case, she highlighted characteristic MRI features, the expanding diagnostic toolkit (including MOG and AQP4 antibodies, CSF oligoclonal bands, and neurofilament light chain), and age-specific differentials such as ADEM and MOGAD. Chitnis summarized current therapeutic options, the importance of rapid, comprehensive workups, and emerging biomarkers and translational research linking clinical care with genomics and biostatistics. She emphasized that pediatric presentations offer key insights into MS immunobiology and early risk factors, informing prevention and treatment strategies across the lifespan.

Original Description

Wednesday, February 18, 2026

Does Multiple Sclerosis Start in Childhood?

Tanuja Chitnis, MD